Opinion

Video

Healthcare Specialties Involved in Managing Patients With Chronic Spontaneous Urticaria 

Author(s):

Brian Keegan, MD, PhD,Giselle Mosnaim, MD

A panel of experts discuss the healthcare specialties that become involved in treating patients with CSU.

Video content above is prompted by the following question(s):

  • Which healthcare specialties are involved in managing patients with CSU, and how can multidisciplinary care be optimized?
  • What are the comorbidities that are most seen in patients with CSU, and how do these affect your management plan?
Related Videos
1 expert in this video
1 expert in this video
4 KOLs are featured in this series
4 KOLs are featured in this series
4 KOLs are featured in this series
4 KOLs are featured in this series
4 KOLs are featured in this series
1 expert in this video
1 expert in this video
1 KOL is featured in this series.
Related Content
Imaging of the eye's retina | Image Credit: © Richman Photo - stock.adobe.com
December 3rd 2024

Gene Therapy Enhances Visual Processing for Inherited Retinal Disease

Kimberly Rath, PharmD
Gene therapy partially restores visual processing in the geniculostriate pathway of patients with Leber congenital amaurosis type 2 while maintaining compensatory activity in the retinotectal pathway.
Managed Care Cast
October 29th 2024

Breaking the Cycle: The Importance of Early Intervention in Hidradenitis Suppurativa

Giuliana Grossi
Prompt care supports mental well-being, as hidradenitis suppurativa is often associated with depression and anxiety due to its physical and social challenges.
Guidelines folder-tashatuvango-stock.adobe.com.jpeg
December 2nd 2024

New Guidelines Clarify EORTC Quality of Life Scores for Chronic Lymphocytic Leukemia

Karen Jacobson-Sive
Meaningful change thresholds for the EORTC Quality of Life Questionnaire in chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) are: −11/+11 for symptom burden, −16/+16 for physical condition/fatigue, and −16/+13 for worries/fears.
Managed Care Cast logo
July 18th 2024

Insurance Insights: Dr Jason Shafrin Estimates DMD Insurance Value

Brooke McCormick
On this episode of Managed Care Cast, we're talking with the author of a study published in the July 2024 issue of The American Journal of Managed Care® that estimates the insurance value of novel Duchenne muscular dystrophy (DMD) treatment.
COVID-19 vaccine | Image Credit: M.Rode-Foto - stock.adobe.com
November 30th 2024

COVID-19 Vaccine Improves Mental Health in Patients With IPF

Brooke McCormick
COVID-19 vaccination significantly reduced anxiety and depression in patients with idiopathic pulmonary fibrosis (IPF), improving their mental health one month after the first dose.
3d illustration of a b cell-sebastianlaulitzki-stock.adobe.com.jpeg
November 29th 2024

sGFAP May Predict Progression Independent of Relapse in BCDT-Treated MS

AJMC Contributor
The findings show that increases in serum glial fibrillary acidic protein throughout B-cell depletion therapy are associated with disability worsening despite not relapsing—known as progression independent of relapse activity.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo